Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient

A multiparametric evaluation

Authors

  • Gustavo Kenji Toko Purcino do Amaral Departament of Pharmacy, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil
  • Felipe Rebello Lourenço Departament of Pharmacy, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil https://orcid.org/0000-0002-2630-151X

DOI:

https://doi.org/10.1590/

Keywords:

Conformity assessment, Consumer’s risk, Measurement uncertainty, Monte Carlo simulation, Multiparametric evaluation, Risk of false decision

Abstract

Medicines must be subject to physical, chemical, and biological analysis to guarantee their quality, safety, and effectiveness. Despite the efforts to ensure the reliability of analytical results, some uncertainty will always be associated with the measured value, which can lead to false decisions regarding conformity/non-conformity assessment. This work aims to calculate the specific risk of false decisions regarding conformity/non-conformity of acetaminophen oral solution dosage form. The acetaminophen samples from five different manufacturers (A, B, C, D, and E) were subject to an active pharmaceutical ingredient assay, density test, and dose per drop test according to the official compendia. Based on measured values and their respective uncertainties, the risk values were calculated using the Monte Carlo method implemented in an MS Excel spreadsheet. The results for two acetaminophen oral solution samples (C and D) provided an increased total risk value of false acceptance (33.1% and 9.6% for C and D, respectively). On the other hand, the results for the other three acetaminophen samples (A, B, and E) provided a negligible risk of false acceptance (0.004%, 0.025%, and 0.045% for A, B, and E, respectively). This indicates that measurement uncertainty is very relevant when a conformity assessment is carried out, and information on the risks of false decisions is essential to ensure proper decisions.

Downloads

Download data is not yet available.

References

Bettencourt da Silva RJN, Lourenço FR, Pennecchi FR, Hibbert DB, Kuselman I. Spreadsheet for evaluation of global risks in conformity assessment of a multicomponent material or object. Chemom Intell Lab Syst. 2019;188;1-5. https://doi.org/10.1016/j.chemolab.2019.02.010

» https://doi.org/10.1016/j.chemolab.2019.02.010

Bettencourt da Silva RJN, Pennecchi FR, Hibbert DB, Kuselman I. Tutorial and spreadsheets for Bayesian evaluation of risks of false decisions on conformity of a multicomponent material or object due to measurement uncertainty. Chemom Intell Lab Syst . 2018;182;109-16. https://doi.org/10.1016/j.chemolab.2018.09.004

» https://doi.org/10.1016/j.chemolab.2018.09.004

Bettencourt da Silva RJN, Williams A. Eurachem/CITAC Guide: Setting and Using Target Uncertainty in Chemical Measurement. 2015. https://eurachem.org

» https://eurachem.org

Brandão LP, Silva V.F, Bassi M, de Oliveira EC. Risk assessment in monitoring of water analysis of a Brazilian river. Molecules 2022;27(11). https://doi.org/10.3390/molecules27113628

» https://doi.org/10.3390/molecules27113628

De Oliveira EC. Use of measurement uncertainty in compliance assessment with regulatory limits. Braz J Anal Chem. 2020;7(28):1-2. http://dx.doi.org/10.30744/brjac.2179-3425.editorial.ecoliveira.N28

» http://dx.doi.org/10.30744/brjac.2179-3425.editorial.ecoliveira.N28

Farmacopéia Brasileira. Vol. 2. Agência Nacional de Vigilância Sanitária (ANVISA). 2019.

Francisco FL, Saviano AM, Lourenço FR. Measuring uncertainty using different approaches: A case study for acetaminophen quantification. J AOAC Int. 2016;99:612-617. https://doi.org/10.5740/jaoacint.15-0199

» https://doi.org/10.5740/jaoacint.15-0199

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH guideline Q8 (R2) on pharmaceutical development. Q8(R2), 2017. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-11.pdf

» https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-11.pdf

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH guideline Q9 (R1) on quality risk management. Q9(R1), 2023. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-17.pdf

» https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-17.pdf

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH guideline Q10 on pharmaceutical quality system. Q10, 2015. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human_en.pdf

» https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human_en.pdf

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH guideline Q14 on analytical procedure development. Q14, 2022. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q14-analytical-procedure-development-step-2b_en.pdf

» https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q14-analytical-procedure-development-step-2b_en.pdf

Kuselman I, Pennecchi F, da Silva R, Hibbert D, Anchutina E. Total risk of a false decision on conformity of an alloy due to measurement uncertainty and correlation of test results. Talanta. 2018;189:666-674. https://doi.org/10.1016/j.talanta.2018.07.049

» https://doi.org/10.1016/j.talanta.2018.07.049

Kuselman I, Pennecchi FR, Bettencourt da Silva RJN, Hibbert DB. Risk of false decision on conformity of a multicomponent material when test results of the components’ content are correlated. Talanta. 2017;174:789-796. https://doi.org/10.1016/j.talanta.2017.06.073

» https://doi.org/10.1016/j.talanta.2017.06.073

Lourenço FR, Bettencourt da Silva RJN. Risk of false conformity decisions of multicomponent items controlled by correlated measurement results due to the sharing of analytical steps. Talanta. 2019;196:174-181. https://doi.org/10.1016/j.talanta.2018.12.021

» https://doi.org/10.1016/j.talanta.2018.12.021

Matos ACH, de Oliveira EC. Risk assessment and optimisation of sulfur in marketing fuels. Fuel. 2021;122705. https://doi.org/10.1016/j.fuel.2021.122705

» https://doi.org/10.1016/j.fuel.2021.122705

Moreira CS, Lourenço FR. In Vitro Therapeutic Equivalence of Acetaminophen Oral Solution in Dripper Bottle. Latin Am J Pharm. 2015;34:78-85.

Pennecchi FR, Kuselman I, Bettencourt da Silva RJN, Hibbert DB. Risk of a false decision on conformity of an environmental compartment due to measurement uncertainty of concentrations of two or more pollutants. Chemosphere. 2018;202;165-76. https://doi.org/10.1016/j.chemosphere.2018.03.054

» https://doi.org/10.1016/j.chemosphere.2018.03.054

Separovic L, Bettencourt da Silva RJN, Lourenço FR. Determination of intrinsic and metrological components of the correlation of multiparameter products for minimising the risks of false conformity decisions. Measurement. 2021;180:109531. https://doi.org/10.1016/j.measurement.2021.109531

» https://doi.org/10.1016/j.measurement.2021.109531

Separovic L, Bettencourt da Silva RJN, Lourenço FR. Improved spreadsheet method for determination of between components metrological correlation due to the sharing of analytical steps. Chemom Intell Lab Sys. 2019;89:161-168. https://doi.org/10.1016/j.chemolab.2019.05.002

» https://doi.org/10.1016/j.chemolab.2019.05.002

Separovic L, Lourenço FR. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures. J Pharm Biomed Anal. 2020;184:1-7. https://doi.org/10.1016/j.jpba.2020.113203

» https://doi.org/10.1016/j.jpba.2020.113203

Separovic L, Lourenço FR. Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures. J Pharm Biomed Anal. 2019;171:73-80. https://doi.org/10.1016/j.jpba.2019.04.005

» https://doi.org/10.1016/j.jpba.2019.04.005

Separovic L, Simabukuro RS, Couto AR, Bertanha MLG, Dias FRS, Sano AY, et al. Measurement Uncertainty and Conformity Assessment Applied to Drug and Medicine Analyses - A Review. Crit Rev Anal Chem. 2023;53(1):123-138. https://doi.org/10.1080/10408347.2021.1940086

» https://doi.org/10.1080/10408347.2021.1940086

Williams A, Magnusson B. Eurachem/CITAC Guide: Use of uncertainty information in compliance assessment. 2021. https://eurachem.org

» https://eurachem.org

Downloads

Published

2024-11-05

Issue

Section

Article

How to Cite

Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: A multiparametric evaluation. (2024). Brazilian Journal of Pharmaceutical Sciences, 60. https://doi.org/10.1590/